Abiopharma

New Form SCHEDULE 13G - SciSparc Ltd. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001213900-26-028338 <b>Size:</b> 7 KB

Securities Fraud Investigation Into Medical Properties Trust, Inc. (MPT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

New Form ARS - Moderna, Inc. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001308179-26-000080 <b>Size:</b> 1 MB

New Form S-8 - Aprea Therapeutics, Inc. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001104659-26-028509 <b>Size:</b> 172 KB

The Coca-Cola Company Announces Maria Elena Lagomasino Will Conclude Her Service on the Board of Directors

Securities Fraud Investigation Into IperionX Limited (IPX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Lifezone Announces Release Date of 2025 Financial Results and Notice of Financial Results Investor Webcast

New Form SCHEDULE 13G - SciSparc Ltd. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001213900-26-028316 <b>Size:</b> 7 KB

New Form SCHEDULE 13G - AN2 Therapeutics, Inc. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001831942-26-000014 <b>Size:</b> 15 KB

New Form 424B5 - Atara Biotherapeutics, Inc. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001193125-26-108386 <b>Size:</b> 115 KB

Cyngn Inc. Announces $9.65 Million Registered Direct Offering, Priced at the Market Under Nasdaq Rules

Cognizant Expands AI Infrastructure Capabilities with Launch of Cognizant AI Factory

New Form SCHEDULE 13D/A - Vor Biopharma Inc. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001104659-26-028470 <b>Size:</b> 18 KB

New Form 10-K - Perspective Therapeutics, Inc. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0000728387-26-000004 <b>Size:</b> 18 MB

New Form S-8 - Black Diamond Therapeutics, Inc. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001104659-26-028461 <b>Size:</b> 195 KB